WW 268 (Lisinopril 20 mg)
Pill imprint WW 268 has been identified as Lisinopril 20 mg.
Lisinopril is used in the treatment of high blood pressure; diabetic kidney disease; heart failure; alport syndrome; coronary artery disease (and more), and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Lisinopril 20 mg is not a controlled substance under the Controlled Substance Act (CSA).
- WW 268
- 20 mg
- 8.00 mm
- Prescription only
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- West-Ward Pharmaceutical Corporation
- National Drug Code (NDC):
- Inactive Ingredients:
- corn starch
silicon dioxide colloidal
calcium phosphate dibasic anhydrous
ferric oxide red
sodium starch glycolate type A potato
|NDC Code||Manufacturer / Repackager|
|24658-0243||Blu Pharmaceuticals LLC|
|66336-0741||Dispensing Solutions Inc. (repackager)|
|67544-0134||Prepak Systems Inc (repackager)|
Note: Inactive ingredients may vary.
More about lisinopril
Related treatment guides
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.